CoChat

Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum

Open access

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

The rapidly evolving field of metabolomics aims at a comprehensive measurement of ideally all endogenous metabolites in a cell or body fluid. It thereby provides a functional readout of the physiological state of the human body. Genetic variants that associate with changes in the homeostasis of key lipids, carbohydrates, or amino acids are not only expected to display much larger effect sizes due to their direct involvement in metabolite conversion modification, but should also provide access to the biochemical context of such variations, in particular when enzyme coding genes are concerned. To test this hypothesis, we conducted what is, to the best of our knowledge, the first GWA study with metabolomics based on the quantitative measurement of 363 metabolites in serum of 284 male participants of the KORA study. We found associations of frequent single nucleotide polymorphisms (SNPs) with considerable differences in the metabolic homeostasis of the human body, explaining up to 12% of the observed variance. Using ratios of certain metabolite concentrations as a proxy for enzymatic activity, up to 28% of the variance can be explained (p-values 10(-16) to 10(-21)). We identified four genetic variants in genes coding for enzymes (FADS1, LIPC, SCAD, MCAD) where the corresponding metabolic phenotype (metabotype) clearly matches the biochemical pathways in which these enzymes are active. Our results suggest that common genetic polymorphisms induce major differentiations in the metabolic make-up of the human population. This may lead to a novel approach to personalized health care based on a combination of genotyping and metabolic characterization. These genetically determined metabotypes may subscribe the risk for a certain medical phenotype, the response to a given drug treatment, or the reaction to a nutritional intervention or environmental challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1000282

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic illustration of the role of intermediate phenotypes (IPs), such as metabolic traits, demonstrated at the examples of two genes that code for major enzymes of the long-chain fatty acid metabolism (FADS1 and LIPC). We show that new information on the functional basis of the observed associations can be inferred from the biochemical properties of the affected metabolites. Moreover, both genes were previously reported to be associated with common clinical phenotypes, FADS1 in an extent which would not attract immediate attention for follow-up in a genome-wide context. Since several genes and pathways are involved in the development of a clinical endpoint, the IP focuses on one pathway (e.g., cholesterol or a given metabotype) which is already known to be involved in the clinical endpoint (e.g. coronary artery disease (CAD)). It is much easier to identify the genes which are associated with the IP since the associations of genetic variation with the IP is much stronger than with the clinical endpoint. Environmental factors interact at different levels with the IPs and thereby add to the variability in the system. The closer the IP is related to the genetic polymorphism, the stronger the association is expected to be. In our case the association reflects enzymatic activity of FADS1 and LIPC which results in very strong effect sizes of the genetically determined metabotype.
Figure 1 Schematic illustration of the role of intermediate phenotypes (IPs), such as metabolic traits, demonstrated at the examples of two genes that code for major enzymes of the long-chain fatty acid metabolism (FADS1 and LIPC). We show that new information on the functional basis of the observed associations can be inferred from the biochemical properties of the affected metabolites. Moreover, both genes were previously reported to be associated with common clinical phenotypes, FADS1 in an extent which would not attract immediate attention for follow-up in a genome-wide context. Since several genes and pathways are involved in the development of a clinical endpoint, the IP focuses on one pathway (e.g., cholesterol or a given metabotype) which is already known to be involved in the clinical endpoint (e.g. coronary artery disease (CAD)). It is much easier to identify the genes which are associated with the IP since the associations of genetic variation with the IP is much stronger than with the clinical endpoint. Environmental factors interact at different levels with the IPs and thereby add to the variability in the system. The closer the IP is related to the genetic polymorphism, the stronger the association is expected to be. In our case the association reflects enzymatic activity of FADS1 and LIPC which results in very strong effect sizes of the genetically determined metabotype.CC BY · PubMed Central
Figure 2 P-values of association assuming an additive genetic model, superposing the results obtained from all genome-wide tested metabolic traits. Chromosomal location is indicated by different colors on the x-axis, negative logarithmic p-values are reported on the y-axis. The top ranking SNPs together with the closest gene and the most significant associating metabolite(s) are indicated. A complete list of all associations with p<10−6 is provided in Table S1, together with significant associations from previous GWA studies with medical phenotypes. Metabolite abbreviations are explained in the material and methods section and a full list of all measured metabolites is provided as supplementary data.
Figure 2 P-values of association assuming an additive genetic model, superposing the results obtained from all genome-wide tested metabolic traits. Chromosomal location is indicated by different colors on the x-axis, negative logarithmic p-values are reported on the y-axis. The top ranking SNPs together with the closest gene and the most significant associating metabolite(s) are indicated. A complete list of all associations with p<10−6 is provided in Table S1, together with significant associations from previous GWA studies with medical phenotypes. Metabolite abbreviations are explained in the material and methods section and a full list of all measured metabolites is provided as supplementary data.CC BY · PubMed Central
Figure 3 Boxplots of the metabolite concentrations of five top ranking associations as a function of genotype. They show the differentiation of the population that is induced by these genetically determined metabotypes (0 = major allele homozygote, 1 = heterozygote, 2 = minor allele homozygote). Boxes extend from 1st quartile (Q1) to 3rd quartile (Q3); median is indicated as a horizontal line; whiskers are drawn to the observation that is closest to, but not more than, a distance of 1.5(Q3-Q1) from the end of the box. Observations that are more distant than this are shown individually on the plot. The number of individuals in each group is given below the boxes. P-values for these associations are given in Table 1.
Figure 3 Boxplots of the metabolite concentrations of five top ranking associations as a function of genotype. They show the differentiation of the population that is induced by these genetically determined metabotypes (0 = major allele homozygote, 1 = heterozygote, 2 = minor allele homozygote). Boxes extend from 1st quartile (Q1) to 3rd quartile (Q3); median is indicated as a horizontal line; whiskers are drawn to the observation that is closest to, but not more than, a distance of 1.5(Q3-Q1) from the end of the box. Observations that are more distant than this are shown individually on the plot. The number of individuals in each group is given below the boxes. P-values for these associations are given in Table 1.CC BY · PubMed Central
Figure 4 Boxplots of the strongest associations of metabolite concentration ratios with polymorphisms in the FADS1 (A; p = 2.4×10−22), SCAD (B; p = 9.3×10−17), and MCAD (C; p = 7.6×10−17) genes (see legend to Figure 3 for details). The metabolic efficiencies of the reactions that are catalyzed by these three enzymes differ considerably between individuals of different genotype.
Figure 4 Boxplots of the strongest associations of metabolite concentration ratios with polymorphisms in the FADS1 (A; p = 2.4×10−22), SCAD (B; p = 9.3×10−17), and MCAD (C; p = 7.6×10−17) genes (see legend to Figure 3 for details). The metabolic efficiencies of the reactions that are catalyzed by these three enzymes differ considerably between individuals of different genotype.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 2

  1. KM Weinberger, 2008, Metabolomics in diagnosing metabolic diseases., Ther Umsch, 65, 487
  2. KM Weinberger, 2005, Using Comprehensive Metabolomics to Identify Novel Biomarkers., Screening Trends in Drug Discovery, 6, 42

Cited by

See all 752

Metadata

Authors
Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.-W., Wichmann, H.-E., Weinberger, K. M., Adamski, J., Illig, T., & Suhre, K.
Affiliations
  • Helmholtz Munich (DE)
  • Innsbruck Medical University (AT)
  • TUM Klinikum (DE)
  • Biocrates Life Sciences (Austria) (AT)
Corresponding author
Suhre, Karsten
Venue
PLoS Genetics
Published
2008-11-28
Volume
4
Issue
11
Pages
e1000282
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2164339823
Cited by
737
References
40
Citations by year
2026: 12 · 2025: 30 · 2024: 33 · 2023: 31 · 2022: 28 · 2021: 41 · 2020: 51 · 2019: 41 · 2018: 47 · 2017: 40 · 2016: 49 · 2015: 54 · 2014: 48 · 2013: 60 · 2012: 55
FWCI
21.90
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • mediaTUM (Technical University of Munich) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Site cant be reached (submittedVersion, cc-by)
Funders
  • Bayerische Akademie der Wissenschaften
  • Leibniz-Gemeinschaft
  • Münchner Zentrum für Gesundheitswissenschaften
  • Leibniz-Rechenzentrum
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
genome-wide association study, serum metabolites, metabolomics, single nucleotide polymorphisms, genetic variants, metabolic homeostasis, enzyme activity, FADS1, hepatic lipase, SCAD, medium-chain acyl-CoA dehydrogenase, metabolic phenotypes, personalized medicine, KORA study
MeSH terms
Delta-5 Fatty Acid Desaturase, Blood Proteins, Genetics, Humans, Male, Organic Chemicals, Phenotype, Phosphoproteins, Genome, Human, Polymorphism, Single Nucleotide, Ubiquitin-Protein Ligases, Fatty Acid Desaturases, Genome-Wide Association Study, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. https://app.cochat.ai/papers/10.1371/journal.pgen.1000282
The paper
Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.-W., Wichmann, H.-E., Weinberger, K. M., Adamski, J., Illig, T., & Suhre, K. (2008). Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1000282

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.